Earnings Feed
Start Free
|4Nov 18, 4:31 PM ET

Corrigan Catherine 4

4 · EXPONENT INC · Filed Nov 18, 2025

Insider Transaction Report

Form 4
Period: 2025-11-17
EXPONENT INCEXPO
Corrigan Catherine
DirectorPresident & CEO
Transactions
  • Exercise/Conversion

    Common Stock

    2025-11-17$25.41/sh+3,225$81,931→ 86,654 total
  • Sale

    Common Stock

    2025-11-17$70.20/sh−3,225$226,411→ 83,429 total
  • Exercise/Conversion

    Common Stock

    2025-11-17$29.05/sh+2,380$69,139→ 85,809 total
  • Sale

    Common Stock

    2025-11-17$70.74/sh−1,675$118,487→ 84,134 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2025-11-17−3,225→ 19,353 total
    Exercise: $25.41Exp: 2026-07-29→ Common Stock (3,225 underlying)
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2025-11-17−2,380→ 19,038 total
    Exercise: $29.05Exp: 2027-02-16→ Common Stock (2,380 underlying)
Footnotes (3)
  • [F1]Stock sale was to cover the option exercise price and taxes.
  • [F2]The stock option becomes exercisable in four equal annual installments.
  • [F3]Not applicable.

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT